Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation.
about
Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.Isolated deletion of the long arm of chromosome 20 [del(20q12)] in myelodysplastic syndrome: a case report and literature review.Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.Durable hematological and major cytogenetic response in a patient with isolated 20q deletion myelodysplastic syndrome treated with lenalidomideClinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies.Diagnostics and Prognostication of Myelodysplastic Syndromes.Therapy-related myelodysplastic syndrome presenting as isolated thrombocytopenia following chemotherapy for acute myeloid leukemia in a Chinese child.Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
P2860
Q33392291-4EAA2DE3-8DBF-4E54-B342-04C1D6525B1CQ33398815-34976D52-67F7-4989-92A9-90C0B298CFD5Q33410568-069A7D75-8AE6-47B1-8156-CB7C1E0CCB36Q33434835-1CD7FBAF-0736-44BB-BA9F-B4BBE0ED275EQ35563771-2C59C16F-E691-45A7-A874-D92107E7C1FEQ37365459-ADBD1303-5509-4FD1-9BC7-0A09E75C32E3Q38259434-FE0F243D-E40C-499A-A6D1-B9C00FA1759CQ38564470-E8C9F550-B2A8-435E-8511-295CAB0FA30AQ41693113-7286C97F-F4E3-4806-B2B6-8CD044B6E5EDQ42757406-5807CBD1-34FF-432C-8556-2BDDB6F4D6F6Q44276987-DAD35433-7CE0-43FD-948F-5514F42EAAA0Q51804731-25C81B9F-C2CC-4683-AD07-03B4B8C5F273Q53088619-D842B293-4085-485A-8693-A8670AC5B930Q54047543-3300B07E-3120-410A-961B-D61DEEE3896B
P2860
Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@ast
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@en
type
label
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@ast
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@en
prefLabel
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@ast
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@en
P2093
P2860
P1476
Myelodysplastic syndrome with ...... thrombocytopenic presentation.
@en
P2093
Chad P Soupir
Raavi Gupta
Robert P Hasserjian
Vandita Johari
P2860
P304
P356
10.1111/J.1365-2141.2007.06776.X
P407
P577
2007-08-30T00:00:00Z